Skip to content

Improving Pulmonary Hypertension Screening by Echocardiography

Improving Pulmonary Hypertension Screening by Echocardiography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06038149
Acronym
IMPULSE
Enrollment
200
Registered
2023-09-14
Start date
2023-11-11
Completion date
2026-03-20
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Hypertension

Brief summary

This study aims to assess the application of the novel IMPULSE algorithm for the detection of pulmonary hypertension (PH) in those with a low or intermediate probability of PH according to the British Society of Echocardiography (ESC) and European Society of Cardiology (ESC) guidelines.

Detailed description

This is a prospective, multi-centre cross-sectional study with a planned 18 month longitudinal component. Participants will be recruited from patients referred for the first time for transthoracic echocardiography at the Royal United Hospitals Bath National Health Service (NHS) Foundation Trust, Royal Free Hospital NHS Foundation Trust, Sheffield Teaching Hospitals, Royal Papworth Hospital, and Golden Jubilee Hospital. The investigators will prospectively recruit patients without a diagnosis of Pulmonary Hypertension. Transthoracic echocardiographic (TTE) imaging will be performed in line with British Society of Echocardiography minimum dataset guidelines, and comprehensive right heart echocardiographic imaging and analysis will be performed following the British Society of Echocardiography recommendations for assessing right heart function, in addition to the IMPULSE algorithm; A right ventricular free wall longitudinal strain value of less than -23%, or, right ventricular fractional area change (FAC) less than 35% in females/30% in males, in addition to a right ventricular isovolumetric relaxation time in excess of 73ms in patients with low/Intermediate probability of PH by current guidelines would categorise that patient as being IMPULSE positive.

Interventions

A painless ultrasound scan of the heart.

Sponsors

Royal United Hospitals Bath NHS Foundation Trust
Lead SponsorOTHER
Janssen-Cilag Ltd.
CollaboratorINDUSTRY
Royal Free Hospital NHS Foundation Trust
CollaboratorOTHER
Sheffield Teaching Hospitals NHS Foundation Trust
CollaboratorOTHER
Royal Papworth Hospital
CollaboratorOTHER_GOV
Golden Jubilee National Hospital
CollaboratorOTHER_GOV
University of Bath
CollaboratorOTHER
Liverpool John Moores University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Unexplained breathlessness * Risk factors for Pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH) * Unexplained elevation of B-type natriuretic peptide (BNP/proBNP) * Referred for catheterisation.

Exclusion criteria

* ESC / BSE echo high probability of PH * Known or suspected congenital heart disease * Patients unlikely to benefit from management of PH or its underlying causes.

Design outcomes

Primary

MeasureTime frameDescription
Analysis of the IMPULSE algorithm in the assessment of pulmonary hypertension18 monthsAnalyse sensitivity, specificity, positive predictive value, negative predictive value, accuracy of IMPULSE algorithm on the assessment of PH.
Analysis of the IMPULSE algorithm in comparison to existing guidlines18 monthsAnalyse sensitivity, specificity, positive predictive value, negative predictive value, accuracy of IMPULSE algorithm in comparison with the existing ESC PH guidelines.

Secondary

MeasureTime frameDescription
Analysis of additional echocardiographic measurements of right heart systolic function not utilised in the assessment of pulmonary hypertension.18 monthsValues from echocardiographic measures of right heart systolic function not currently used in the ESC/BSE echocardiography pulmonary hypertension, or IMPULSE algorithms will be analysed for sensitivity, specificity, positive predictive value and negative predictive value in context with with values obtained during formal pulmonary hypertension diagnosis via right heart catheter, in patients already found to have a mild to intermediate probability of pulmonary hypertension.
Analysis of additional echocardiographic measurements of right heart diastolic function not utilised in the assessment of pulmonary hypertension.18 monthsValues from echocardiographic measures of right heart diastolic function not currently used in the ESC/BSE echocardiography pulmonary hypertension, or IMPULSE algorithms will be analysed for sensitivity, specificity, positive predictive value and negative predictive value in context with with values obtained during formal pulmonary hypertension diagnosis via right heart catheter, in patients already found to have a mild to intermediate probability of pulmonary hypertension.
Analysis of additional echocardiographic measurements of left heart function not utilised in the assessment of pulmonary hypertension.18 monthsValues obtained in the echocardiographic assessment of left heart disease not currently used in the ESC/BSE echocardiography pulmonary hypertension, or IMPULSE algorithms will be analysed for sensitivity, specificity, positive predictive value and negative predictive value in context with values obtained during formal pulmonary hypertension diagnosis via right heart catheter, in patients already found to have a mild to intermediate probability of pulmonary hypertension.

Countries

United Kingdom

Contacts

PRINCIPAL_INVESTIGATORDaniel X Augustine, BSc(Hons)

Royal United Hospitall NHS Foundation Trust

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026